1. Rabbit antithymocyte globulin versus basiliximab in renal transplantation;Brennan;N Engl J Med,2006
2. Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies – a retrospective study;Goumard;Transpl Int,2019
3. Daclizumab versus rabbit antithymocyte globulin in high-risk renal transplants: five-year follow-up of a randomized study;Hellemans;Am J Transplant,2015
4. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients;Hill;Cochrane Database Syst Rev,2017
5. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up;Laftavi;Transplant Proc,2011